AAAAAA

   
Results: 1-8 |
Results: 8
Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution. (vol 6, pg 1150, 2000)
Authors: Smolewski, P Robak, T Krykowski, E Blasinska-Morawiec, M Niewiedomska, H Pluzanska, A Chmielowska, E Zambrano, O
Citation: P. Smolewski et al., Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution. (vol 6, pg 1150, 2000), CLIN CANC R, 6(5), 2000, pp. 2120-2120
Prognostic factors in Hodgkin's disease: Multivariate analysis of 327 patients from a single institution
Authors: Smolewski, P Robak, T Krykowski, E Blasinska-Morawiec, M Niewiadomska, H Pluzanska, A Chmielowska, E Zambrano, O
Citation: P. Smolewski et al., Prognostic factors in Hodgkin's disease: Multivariate analysis of 327 patients from a single institution, CLIN CANC R, 6(3), 2000, pp. 1150-1160
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial
Authors: Robak, T Blonski, JZ Kasznicki, M Blasinska-Morawiec, M Krykowski, E Dmoszynska, A Mrugala-Spiewak, H Skotnicki, AB Nowak, W Konopka, L Ceglarek, B Maj, S Dwilewicz-Trojaczek, J Hellmann, A Urasinski, I Zdziarska, B Kotlarek-Haus, S Potoczek, S Grieb, P
Citation: T. Robak et al., Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial, BLOOD, 96(8), 2000, pp. 2623-2629
Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial
Authors: Robak, T Blonski, JZ Kasznicki, M Blasinska-Morawiec, M Krykowski, E Dmoszynska, A Mrugala-Spiewak, H Skotnicki, AB Nowak, W Konopka, L Ceglarek, B Maj, S Dwilewicz-Trojaczek, J Heilmann, A Urasinski, I Zdziarska, B Kotlarek-Haus, S Potoczek, S Grieb, P
Citation: T. Robak et al., Cladribine with prednisone versus chlorambucil with prednisone as first-line therapy in chronic lymphocytic leukemia: report of a prospective, randomized, multicenter trial, BLOOD, 96(8), 2000, pp. 2723-2729
2-chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia
Authors: Robak, T Blasinska-Morawiec, M Blonski, JZ Dmoszynska, A
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of elderly patients with B-cell chronic lymphocytic leukemia, LEUK LYMPH, 34(1-2), 1999, pp. 151-157
Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission
Authors: Robak, T Wierzbowska, A Blasinska-Morawiec, M Korycka, A Blonski, JZ
Citation: T. Robak et al., Serum levels of IL-6 type cytokines and soluble IL-6 receptors in active B-cell chronic lymphocytic leukemia and in cladribine induced remission, MEDIAT INFL, 8(6), 1999, pp. 277-286
2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland
Authors: Robak, T Blasinska-Morawiec, M Blonski, J Hellmann, A Halaburda, K Konopka, L Kotlarek-Haus, S Potoczek, S Hansz, J Dmoszynska, A Urasinski, I Zdziarska, B Dwilewicz-Trojaczek, J Holowiecki, J Skotnicki, AB
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland, EUR J HAEMA, 62(1), 1999, pp. 49-56
2-chlorodeoxyadenosine (cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger
Authors: Robak, T Blonski, JZ Urbanska-Rys, H Blasinska-Morawiec, M Skotnicki, AB
Citation: T. Robak et al., 2-chlorodeoxyadenosine (cladribine) in the treatment of patients with chronic lymphocytic leukemia 55 years old and younger, LEUKEMIA, 13(4), 1999, pp. 518-523
Risultati: 1-8 |